Spots Global Cancer Trial Database for Endostar in Combination With Chemoradiotherapy in Patient With Advanced Non-small Cell Lung Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Endostar in Combination With Chemoradiotherapy in Patient With Advanced Non-small Cell Lung Cancer
Official Title: Recombinant Human Endostatin (Endostar) Combined With Concurrent Chemoradiotherapy for Advanced Non-small Cell Lung Cancer: A Multicenter, Randomized, Controlled Trial
Study ID: NCT03588494
Conditions
Study Description
Brief Summary: To investigate the safety and efficacy recombinant human endostatin(endostar) durative transfusion combined with cocurrent chemoradiotherapy in advanced non-small cell lung cancer(NSCLC).
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China
Contact Details
Name: Daiyuan Ma, M.D
Affiliation: Affiliated Hospital of North Sichuan Medical College
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
